학술논문

Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Document Type
Article
Source
In Biology of Blood and Marrow Transplantation February 2020 26(2):262-271
Subject
Language
ISSN
1083-8791